MeSH term
Frequency | Condition_Probility | Humans | 61 | 0.0 |
Adult | 10 | 0.0 |
Animals | 22 | 0.0 |
Child | 3 | 0.0 |
Female | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 53 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 6 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Blotting, Western | 8 | 0.0 |
Brain/metabolism | 2 | 0.0 |
Calcium-Binding Proteins/chemistry/*metabolism | 2 | 15.0 |
*Cell Cycle Proteins | 34 | 2.0 |
Chromatography, Affinity | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Nerve Growth Factors/*metabolism | 3 | 3.0 |
Plasmids/metabolism | 2 | 0.0 |
Precipitin Tests | 4 | 0.0 |
Protein Binding | 8 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Rats | 4 | 0.0 |
S100 Proteins/*metabolism | 10 | 18.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Base Sequence | 5 | 0.0 |
Calcium-Binding Proteins/genetics/*metabolism | 4 | 16.0 |
Cells, Cultured | 2 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Ki-67 Antigen/metabolism | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
*Neoplasm Proteins | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Calcium/*metabolism | 9 | 1.0 |
Crystallography, X-Ray | 2 | 0.0 |
Dimerization | 4 | 0.0 |
Models, Molecular | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Gene Expression Profiling | 4 | 0.0 |
Transfection | 4 | 0.0 |
Calcium-Binding Proteins/chemistry | 2 | 28.0 |
Protein Conformation | 4 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
S100 Proteins/*chemistry | 4 | 33.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Immunohistochemistry | 18 | 0.0 |
Prognosis | 2 | 0.0 |
Skin Neoplasms/*metabolism/pathology | 4 | 6.0 |
Cell Division | 3 | 0.0 |
Mice | 11 | 0.0 |
Antibodies, Monoclonal/metabolism | 2 | 0.0 |
Diagnosis, Differential | 3 | 0.0 |
S100 Proteins/analysis/*metabolism | 2 | 50.0 |
Cell Line | 7 | 0.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Binding Sites | 5 | 0.0 |
Calcium-Binding Proteins/*metabolism | 5 | 5.0 |
Fibroblasts/metabolism | 2 | 0.0 |
*S100 Proteins | 3 | 3.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Zinc/*metabolism | 3 | 4.0 |
Male | 16 | 0.0 |
Organ Specificity | 2 | 0.0 |
Astrocytes/*metabolism | 4 | 6.0 |
Neurons/*metabolism | 2 | 0.0 |
S100 Proteins/*genetics | 3 | 15.0 |
Mutation | 2 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
S100 Proteins/*genetics/metabolism | 3 | 60.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Superoxide Dismutase/genetics | 2 | 2.0 |
*Gene Expression Profiling | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 5 | 0.0 |
S100 Proteins/*biosynthesis | 3 | 27.0 |
COS Cells | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Up-Regulation | 3 | 0.0 |
Aged | 8 | 0.0 |
Aged, 80 and over | 6 | 0.0 |
Aging/*physiology | 2 | 0.0 |
Antibody Specificity | 3 | 0.0 |
Middle Aged | 10 | 0.0 |
Nuclear Proteins/analysis | 2 | 1.0 |
Comparative Study | 7 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
S100 Proteins/*analysis | 4 | 8.0 |
Chromosome Mapping | 4 | 0.0 |
*Chromosomes, Human, Pair 1 | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Calcium-Binding Proteins/*analysis | 3 | 23.0 |
Thapsigargin/pharmacology | 2 | 1.0 |
Calcium/metabolism | 2 | 0.0 |
Cattle | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
S100 Proteins/genetics/*metabolism | 2 | 11.0 |
Calcium-Binding Proteins/genetics | 2 | 5.0 |
Blotting, Southern | 2 | 0.0 |
Microscopy, Confocal | 3 | 0.0 |
Rabbits | 2 | 0.0 |
Tumor Markers, Biological/*analysis | 2 | 0.0 |
Glial Fibrillary Acidic Protein/metabolism | 2 | 0.0 |
S100 Proteins/metabolism | 2 | 1.0 |
Adenocarcinoma/*genetics/metabolism | 2 | 5.0 |
Pancreatic Neoplasms/*genetics/metabolism | 2 | 11.0 |
Signal Transduction/physiology | 2 | 0.0 |
Apoproteins/chemistry | 2 | 20.0 |
